No abstract

Dwindling supplies of fossil fuels and their deleterious impacts on human health and the global environment have intensified the search for substitute energy sources. Biodiesel has been identified as a promising renewable energy substitute for diesel fuel due to several comparable and sustainable properties. However, approximately 95% of biodiesel is derived from edible oil crops, threatening the current food supplies. Therefore, the biodiesel production potential from inexpensive, non-edible, and non-conventional bioenergy crops, such as Jatropha (Jatropha curcas L.), has attracted the attention of many researchers, policymakers, and industries globally. Jatropha is considered to be the second-generation biofuel feedstocks for biodiesel production. However, sustainable biodiesel generation from J. curcas oil has not yet been attained, owing to different socio-economic, ecological, and technical factors. This study aimed to synthesize the information from the existing literature on the present status and to identify the knowledge gaps for future research on Jatropha by providing comprehensive information regarding its origin and distribution, morphology, phenology, and reproduction, genetic diversity, its productivity, oil content, and fatty acid composition, the methodology used for extracting biodiesel, and agronomic, economic, and environmental aspects of biodiesel production. The germplasm screening of J. curcas and the exploration of its adaptability and agronomic potential across diverse climates are highly desired to promote this crop as an alternative biofuel crop, particularly in arid and semi-arid regions. Moreover, future research should focus on developing, optimizing, and modernizing the technologies involving seed collection, the processing of seeds, oil extraction, and the production of biodiesel.

Background: Melanoma is a metastatic type of skin cancer that is difficult to treat and the majority of efforts are directed to the design of new drugs. Medicinal Plants have been the primary source of medicines since life on earth; more than 50% of existing cancer treatments is derived from plants. Bauhinia variegata is well-known medicinal plant used from the ancient era to till date for their medicinal values. Scientific literatures have not documented any evidence of the antitumour potential of Bauhinia variegata against B16F10 melanoma tumor model in C57BL mice. The present investigation was undertaken to explore the antitumour activity of Leaf, stem bark and flower extract of Bauhinia variegata against B16F10 melanoma tumour model in C57BL mice. Methods: Hydro-methanolic extract prepared from the leaf, stem bark and flower of Bauhinia variegata were assessed for their antitumor activity. The extracts at doses of 500 and 750 mg/kg b.wt. were given orally along with cyclophosphamide (chemotherapeutic drug) for 40 days for exploring antitumor activity against melanoma tumor (B16F10) in C57BL mice. Inhibition of tumor growth, increase in survival time of animal with treatment, histopathological studies and antioxidant parameter were determined. Results: The Present investigation showed significant effect of the B. variegata L. in preventing melanoma tumor by B16F10 cell line in C57BL/6 mice. As compared with the tumour control group, the remarkable results especially in the group which received B. variegata extract and cyclophosphamide together were obtained for all of the measured parameters. Dose dependent response was observed in tumor volume, inhibition rate, life span time and antioxidant parameter of extracts. Combination treatment of cyclophosphamide and B. variegata extracts showed more pronounced effect. Conclusions: These findings suggest that B. variegata hydromethanolic extract may contain bioactive compounds of potential therapeutic significance which are relatively safe from toxic effects, and can compromise the medicinal use of this plant in folk medicine.

No abstract